Hangzhou-based Wecare Medical, a developer of brain disease diagnosis, monitoring, and treatment products, has reportedly raised tens of millions of renminbi in a Pre-Series A financing round. The round was led by Noyu Capital, with the proceeds earmarked for accelerating the development of temporal interference-based non-invasive deep brain electrical stimulation neural regulation products, expanding the brain science diagnosis and treatment product pipeline, upgrading the Biovital digital health universal technology platform, and building manufacturing and marketing teams.
Investment in Groundbreaking Brain Health Solutions
The investment will fuel the advancement of Wecare Medical’s innovative offerings, which include a wrist strap type multimodal signal acquisition device, disease outbreak monitoring algorithm, and visual data analysis management system. These technologies aim to revolutionize the way brain diseases are diagnosed and treated, providing patients with more accessible and effective solutions.
Wecare Medical’s Commitment to Brain Health
Founded in 2021, Wecare Medical has quickly established itself as a leader in the field of brain health technology. The company’s focus on non-invasive deep brain stimulation and digital health platforms positions it at the forefront of medical innovation, with the potential to significantly improve patient outcomes and quality of life.-Fineline Info & Tech
